Trial · NCT00680186
Results by group50
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 50
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE | Dabigatran 150 mg | Participants with event (up to day 180) | 30 | participants | |
| Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE | Warfarin | Participants with event (up to day 180) | 28 | participants | |
| Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE | Dabigatran 150 mg | Participants with event (up to end of ptp) | 34 | participants | |
| Number of Participants With Recurrent Symptomatic Venous Thromboembolism (VTE) and Deaths Related to VTE | Warfarin | Participants with event (up to end of ptp) | 30 | participants | |
| Number of Participants With Recurrent Symptomatic VTE and All Deaths | Dabigatran 150 mg | Participants with event (up to day 180) | 51 | participants | |
| Number of Participants With Recurrent Symptomatic VTE and All Deaths | Warfarin | Participants with event (up to day 180) | 48 | participants | |
| Number of Participants With Recurrent Symptomatic VTE and All Deaths | Dabigatran 150 mg | Participants with event (up to end of ptp) | 57 | participants | |
| Number of Participants With Recurrent Symptomatic VTE and All Deaths | Warfarin | Participants with event (up to end of ptp) | 51 | participants | |
| Number of Participants With Recurrent Symptomatic DVT | Dabigatran 150 mg | Participants with event (up to day 180) | 25 | participants | |
| Number of Participants With Recurrent Symptomatic DVT | Warfarin | Participants with event (up to day 180) | 17 | participants | |
| Number of Participants With Recurrent Symptomatic DVT | Dabigatran 150 mg | Participants with event (up to end of ptp) | 28 | participants | |
| Number of Participants With Recurrent Symptomatic DVT | Warfarin | Participants with event (up to end of ptp) | 17 | participants | |
| Number of Participants With Recurrent Symptomatic Non-fatal PE | Dabigatran 150 mg | Participants with event (up to day 180) | 7 | participants | |
| Number of Participants With Recurrent Symptomatic Non-fatal PE | Warfarin | Participants with event (up to day 180) | 13 | participants | |
| Number of Participants With Recurrent Symptomatic Non-fatal PE | Dabigatran 150 mg | Participants with event (up to end of ptp) | 9 | participants | |
| Number of Participants With Recurrent Symptomatic Non-fatal PE | Warfarin | Participants with event (up to end of ptp) | 15 | participants | |
| Number of Participants Who Died Due to VTE | Dabigatran 150 mg | Participants with event (up to day 180) | 3 | participants | |
| Number of Participants Who Died Due to VTE | Warfarin | Participants with event (up to day 180) | 0 | participants | |
| Number of Participants Who Died Due to VTE | Dabigatran 150 mg | Participants with event (up to end of ptp) | 3 | participants | |
| Number of Participants Who Died Due to VTE | Warfarin | Participants with event (up to end of ptp) | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00680186/results